CNQ:TSX

Canadian Natural Resources Limited

Data as of 2026-03-10 - not real-time

CA$62.77

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Canadian Natural Resources (CNQ) is trading at CAD 62.77, comfortably above its 20‑day (58.10), 50‑day (51.98) and 200‑day (46.05) simple moving averages, indicating a strong bullish bias. Momentum is further confirmed by a bullish MACD crossover (line 2.95 vs signal 2.75) and a rapidly increasing volume trend. However, the RSI of 82 places the stock in overbought territory, and the price is flirting with the technical resistance at CAD 64.39 while support sits near CAD 52.53. Valuation metrics show a trailing P/E of 19.86 versus an industry average of 20.57, suggesting modest relative cheapness, yet the discounted cash‑flow fair value of only CAD 35.93 implies the market is significantly overvalued (upside/downside –12%). The company delivers a 3.97% dividend yield with a payout ratio of 73%, backed by robust operating cash flow of CAD 15.1 bn and free cash flow of CAD 6.36 bn, supporting dividend sustainability. Recent news highlights a Q4 earnings beat and speculation of a natural‑gas asset acquisition, reinforcing short‑term optimism.
Despite the “Extreme Greed” reading on the Fear‑Greed Index (75.9), the 30‑day volatility of 23.3% and a beta of 0.77 signal moderate market risk. The balance sheet shows CAD 19.7 bn of debt against CAD 0.67 bn of cash, yielding a debt‑to‑equity of 44%, which is manageable given the company’s 25.8% ROE. The modest revenue growth of 1.5% and strong operating margin (19.6%) point to a blend of value and limited growth characteristics. Geographic exposure across Western Canada, the North Sea and Africa adds medium‑level geographic risk, while regulatory risk remains medium in the energy sector. Liquidity is low risk thanks to high average volumes (≈20 M shares) and a market cap of CAD 130.8 bn. In sum, the stock’s technical strength is offset by overvaluation and high short‑term momentum, suggesting a cautious stance now with potential upside in the longer run.

Trading Recommendations

Short Term

< 1 year
sell
Conviction: 7/10

Key Factors

  • RSI in overbought zone
  • Price near technical resistance
  • DCF indicates significant overvaluation

Medium Term

1–3 years
hold
Conviction: 8/10

Key Factors

  • Strong cash flow and dividend yield
  • Bullish MACD and volume
  • Moderate valuation relative to peers

Long Term

> 3 years
buy
Conviction: 9/10

Key Factors

  • Robust ROE and operating margins
  • Sustainable dividend payout
  • Diversified geographic asset base

Key Metrics & Analysis

Financial Health

Revenue Growth1.50%
Profit Margin27.91%
P/E Ratio19.9
ROE25.81%
ROA5.74%
Debt/Equity44.45
P/B Ratio2.9
Op. Cash FlowCA$15.1B
Free Cash FlowCA$6.4B
Industry P/E20.6

Technical Analysis

TrendBullish
RSI82.1
SupportCA$52.53
ResistanceCA$64.39
MA 20CA$58.10
MA 50CA$51.98
MA 200CA$46.05
MACDBullish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Fair ValueCA$35.93
Target PriceCA$55.19
Upside/Downside-12.08%
GradeOvervalued
TypeBlend
Dividend Yield3.97%

Risk Assessment

Beta0.77
Volatility23.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.